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Abstract 
Background Priority setting for new and existing vaccines is a complex but important task. Health outcomes 
or cost-eﬀ ectiveness are not the only criteria for priority ranking of vaccine candidates. Real life prioritisation and 
development of new vaccines invariably involves balancing many programmatic features, including dosage 
requirements and cost (and their consequences on coverage and eﬃ  cacy), developmental risk, interface with existing 
programmes (for example, vaccination schedules and capabilities), focus on special populations, and even the 
strengthening of homeland security or public health aid. We aimed to develop a software tool to assist in the process 
of ranking candidate vaccines.
Methods SMART Vaccines (Strategic Multi-Attribute Ranking Tool for Vaccines) combines population-speciﬁ c data 
about demographics, health burdens, costs of disease treatment, and design attributes of potential new vaccines 
to support a multi-attribute utility model. The software oﬀ ers 28 total attributes (plus up to seven user-deﬁ ned 
attributes) from which users can select and weight a subset (maximum of 10) to create SMART Scores to rank 
candidate vaccines. Sensitivity-analysis tools built into SMART Vaccines allow users to specify the most desirable 
target product proﬁ les for a single disease, or the ranking of candidate vaccines across diﬀ erent diseases. The 
programme also allows users to add attributes to the model, and to specify the weights given to the seleted set 
of attributes used in evaluation of vaccine candidates.
Findings Preliminary testing with a range of public health organisations and vaccine developers has demonstrated that 
the concept underlying SMART Vaccines can be expanded for comparisons between public health interventions 
(treatment versus prevention of disease options), and even to quite diﬀ erent uses such as vaccines for animal health.  
Interpretation Early uses of SMART Vaccines have demonstrated that the multi-criteria approach not only enhances 
transparency in public health decision making, but also allows incorporation of many inﬂ uential factors that 
remain hidden or unrecognized in more traditional cost-eﬀ ectiveness analysis. Furthermore, use of SMART 
Vaccines facilitates decision convergence when stakeholder interests have conﬂ icting priorities. To bolster the further 
development of SMART Vaccines, we envision a user community with research universities, especially those with 
strengths in global public health, to act as the software host. 
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